JOIN OUR TEAM
Transparency, ingredients, and clear labeling are important to consumers of nutritional supplements and probiotics. These are also substantial to reputable manufacturers in these markets looking to educate consumers on product benefits and to distance their brands from products on the market with less science supporting their claims and benefits. In January 2017, the Council for
Kline is now working on our largest I&I market study, Janitorial and Housekeeping Cleaning Products: U.S. Market Analysis and Opportunities, and we have uncovered several trends that will significantly change the market in the near future. Rising labor costs with minimum wage increases are driving industrial and institutional (I&I) end users to cut back on
After a lull following the global recession of 2009, merger and acquisition activity heated back up in 2013 and strongly continues into 2014. Among the most notable transactions so far this year are Henkel’s acquisition of three U.S. professional hair care brands, Sexy Hair, Alterna, and Kenra; Bayer’s purchase of Merck’s OTC and consumer care
The latest market data just released by Kline on the U.S. beauty industry illustrates that although the market grew by 3.4% in 2012, there were varying levels of success where some of the key players fared better than others. Procter & Gamble (P&G) remains the clear leader in the U.S. personal care market, which Kline
Rx-to-OTC switch brands continue to be major game changers on the OTC market, whether promoting strong gains or causing steep declines. Traditional OTC lines are delivering growth as they have expanded to meet consumer needs with the Centrum (Pfizer) and One-A-Day (Bayer) vitamin lines. Both of these lines using broad reaching marketing campaigns have had success with new product launches.
From 2010 to 2011, the U.S. OTC drug market posted a gain of 2.4% from $20.9 billion in 2010 to $21.4 billion in 2011 at the manufacturers’ level. The fastest growing categories include allergy relief products, which grew 16.3% in 2011 aided by the market launch of Rx-to-OTC switch brand Allegra (Sanofi-Aventis) and the strong
